Aleva Neurotherapeutics raised €9.5M in a Series A round in Aug 2011. The company is based in Lausanne, Switzerland. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €9.5M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
